Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Avicenna

Financiado

Cerrado

A Strategy for In Silico Clinical Trials

Avicenna, an Arabian physician and philosopher (980-1037), in his Canon of Medicine, first gave a formal structure to the process of evaluating the effect of a treatment on a disease. Since then, the fundamental nature of clinical... ver más

30/09/2015

USFD

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

THE UNIVERSITY OF SHEFFIELD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 4 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-09-30 No tenemos la información de la convocatoria

0% 84% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

4 Participantes

USFD

0.00€ | Lider

LYNKEUS

N.D. | Participante

VELTHA

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

REPO-TRIAL An in silico based approach to improve the efficacy and prec... 6M€ Cerrado

INVENTS Innovative designs, extrapolation, simulation methods and ev... 6M€ Cerrado

ELVIS ELEM Virtual Heart Populations for Supercomputers 4M€ Cerrado

ISW In Silico World Lowering barriers to ubiquitous adoption of... 8M€ Cerrado

CompBioMed2 A Centre of Excellence in Computational Biomedicine 8M€ Cerrado

CPCTAS CENTRE FOR PRE CLINICAL TESTING OF ACTIVE SUBSTANCES 1M€ Cerrado

Líder del proyecto

THE UNIVERSITY OF SHEFFIELD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Avicenna, an Arabian physician and philosopher (980-1037), in his Canon of Medicine, first gave a formal structure to the process of evaluating the effect of a treatment on a disease. Since then, the fundamental nature of clinical trials has changed surprisingly little. The beginning of the 21st century, however, saw the birth of a completely new way to investigate living organisms through computer simulations, called in silico medicine. It is now time to explore systematically how computer simulations can be used to improve clinical trials of drugs, devices, and biotechnology products. We propose the development of a "coordination and support" action, named after the great physician Avicenna, which will establish, in the span of 24 months, a partnership between biomedical industries and European research organisations, with the purpose of developing the technology, methods, protocols, and standards required in order to make possible the use of computer simulations before real clinical trials. The aim of this will be to reduce the costs and the risks (both clinical and financial) involved in trials, and ultimately increase the rate of innovation in healthcare. This action will be designed around two fundamental assumptions:a) The primary users of in silico clinical trials technologies are the biomedical industries;b) The type of research required to develop the necessary technology, methods, protocols, and standards is pre-competitive in nature, and thus should facilitate multiple biomedical industries competing in the same market to collaborate around their development and use.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores